What is Glooko?
Glooko is dedicated to enhancing health outcomes for individuals with chronic conditions through its intelligent, connected care platform. By revolutionizing the patient-provider connection, Glooko drives patient engagement and adherence via digital therapeutics. Its proven technologies are instrumental in accelerating the speed and efficiency of clinical trials, positioning the company as a key innovator in the digital health and medical technology landscape. The company's focus on personalized care solutions addresses critical needs in managing long-term health challenges.
How much funding has Glooko raised?
Glooko has raised a total of $190.5M across 7 funding rounds:
Angel/Seed
$1M
Series A
$7M
Series B
$16.5M
Series C
$35M
Debt
$1M
Series D
$30M
Series F
$100M
Angel/Seed (2011): $1M with participation from Vint Cerf, Annad Rajarman, Judy Estrin, Xtreme Labs, Bill Campbell, Anand Agarawala, Venky Harinarayan, Social+Capital, Russel Hirsch, and Andy Hertzfeld
Series A (2014): $7M led by The Social+Capital Partnership and Samsung Ventures
Series B (2015): $16.5M supported by Samsung Ventures, Medtronic, The Social + Capital Partnership, and Canaan Capital
Series C (2017): $35M featuring Medtronic, Mayo Clinic, Insulet, Samsung NEXT, Canaan Partners, and Georgian
Debt (2020): $1M backed by PPP
Series D (2021): $30M with participation from Canaan Partners, Health Catalyst Capital Management, Mayo Clinic, Novo Nordisk, Georgian, and Insulet
Series F (2024): $100M led by Georgian and Health Catalyst Capital Management
Key Investors in Glooko
Medtronic
Medtronic is a global leader in medical technology, providing innovative therapies and devices for chronic diseases. Their investment in Glooko highlights a strategic interest in connected care solutions for diabetes and other conditions.
Canaan Partners
Canaan is an early-stage venture capital firm specializing in technology and healthcare investments. Their backing of Glooko indicates a belief in the company's potential for significant growth in the digital health sector.
The Social + Capital Partnership
Social Capital is an investment firm focused on transformative ideas and technologies aimed at creating positive societal impact. Their involvement suggests alignment with Glooko's mission to improve health outcomes.
What's next for Glooko?
With its substantial funding history, including a recent major strategic investment, Glooko is well-positioned for continued expansion and innovation. The company's trajectory suggests a focus on scaling its platform, further developing its digital therapeutics, and potentially exploring new therapeutic areas or geographical markets. The consistent backing from strategic investors like Medtronic and Mayo Clinic indicates a strong market validation and a clear path toward solidifying its leadership in the connected health ecosystem. Future growth will likely involve deeper integration with healthcare systems and a continued emphasis on data-driven insights to improve patient care and clinical research.
See full Glooko company page
